Global Allergic Rhinitis Treatment Market 2023: Immunotherapy Treatment Segment Projected to be the Fastest Growing Segment over the Forecast Period

The market for allergic rhinitis treatment includes various types of medications, such as antihistamines, nasal corticosteroids, decongestants, and leukotriene modifiers. These medications can be taken orally or applied topically to the nasal passages. Additionally, allergen immunotherapy (allergy shots) may also be used as a long-term treatment option for allergic rhinitis. The market for allergic rhinitis treatment is expected to grow in the coming years due to an increase in the prevalence of allergic diseases and the development of new and more effective treatment options.

Request For Free Sample Report of "Allergic Rhinitis Treatment Market"@ https://www.persistencemarketresearch.com/samples/12154

"Technological advancements in the medical world and rising prevalence of foodborne diseases will primarily build the market for allergic rhinitis treatment globally. Secondarily, strategic partnerships and synergies between big brands, soaring usage of second-generation multiplex immunoassay, and augmenting R&D activities in life sciences and molecular diagnostics will support the market surge within the next few years. Over 2016-2020, the global AR treatment market will reach US$ 14 Bn, which will further take a leap to US$ 16.038 Bn by the end of 2024. Over 2016-2024, the market is likely to see impressive growth at a healthy CAGR of 7.5%."

Merck & Co. and Johnson & Johnson are concentrating on new product development, such as nasal sprays.
Boehringer Ingelheim will continue to contribute a major share to the market through an increased focus on R&D and a strong distribution network.
Sanofi S.A. is also focusing more on increasing R&D investments directed to expanded sales.
In addition to growing R&D efforts, AstraZeneca is also emphasizing on innovation of technologically advanced products and acquisition of selective regional players.
GlaxoSmithKline PLC and Alcon (Novartis AG) are prioritising cost-effective product development for long-term profits; Alcon specifically aims to tap into emerging markets.
Acquisition of players from the same segment and different region will be a key strategy of Teva Pharmaceutical Industries Ltd., which targets production capacity expansion.

Buy Full Report Now @ https://www.persistencemarketresearch.com/checkout/12154

By disease type, perennial AR segment will remain dominant with around 47% market value share in 2024, gaining around 123 BPS throughout the forecast period. On the other hand, despite losing over 30 BPS over 2016-2024, occupational AR will continue to be the second largest segment with over 35% revenue share at the end of the assessment period. While the revenues of the former are expected to surpass US$ 7.0 Bn, the latter will possibly exceed a value of US$ 5.0 Bn by the end of 2024.

By treatment type, immunotherapy treatment segment is expected to be the fastest growing segment over the forecast owing to introduction of new immunotherapy based products, followed by antihistamines segment. However, antihistamines will continue to be the leading treatment type segment with over 50% share in 2024, followed by corticosteroids with over 31% share.

Based on route of administration, oral route of administration segment will cover nearly half of the market in terms of value, whereas nasal route of administration segment is anticipated to capture around 38% share of the total market value in 2024. Intravenous segment is foreseen to witness a higher CAGR compared to others, which can uplift the sales revenues of this segment to cross US$ 1.25 Bn in 2024.

On the basis of distribution channel, retail pharmacies will account for higher revenues than hospital pharmacies throughout the assessed period. Retail pharmacy revenues are likely to surpass US$ 7.0 Bn, growing at the fastest CAGR of 3.9% over 2016-2024. Whereas, hospital pharmacies will reach over US$ 5.0 Bn, accounting for around 31% share of the market value in 2024.

Request Customization @ https://www.persistencemarketresearch.com/request-customization/12154

Key Questions Answered in This Report.

What are the Roadblocks for Allergic Rhinitis Treatment Market Suppliers?
What are the Key Opportunities for Allergic Rhinitis Treatment Market Manufacturers?
How is Focus on Safety Influencing Allergic Rhinitis Treatment Market Demand?
What is the Regulatory Impact on Global Sales of Allergic Rhinitis Treatment Market?
Which Region Offers the Largest Opportunity for Sales of Allergic Rhinitis Treatment Market?
Where Does the U.S. Stand in the Market for Allergic Rhinitis Treatment Market?
What Is the Outlook for Allergic Rhinitis Treatment Market Manufacturers in China?
Why is Germany a Lucrative Market for Allergic Rhinitis Treatment Market Manufacturers?
Why Will Belgium Outpace Other European Markets for Allergic Rhinitis Treatment Market?
Why is There High Demand for Tires in Allergic Rhinitis Treatment Market?
Why are Sales of Allergic Rhinitis Treatment Market Surging?

For More Premium Insights, Check out the Link:

Mri Systems Market -https://www.prnewswire.com/news-releases/mri-systems-market-is-expected-to-register-a-cagr-of-6-5-over-the-forecast-period-2021-2031---persistence-market-research-301484669.html

Psoriasis Drugs Market -https://www.prnewswire.com/news-releases/psoriasis-drugs-market-is-predicted-to-progress-at-a-cagr-of-6-5-to-reach-a-valuation-of-us-21-48-bn-by-2031--301482350.html

Media Contact:
Persistence Market Research
305 Broadway,7th Floor New York City, NY 10007 United States
Call +1-646-568-7751
Call +1 800-961-0353
sales@persistencemarketresearch.com

About Us

Persistence Market Research is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. Persistence Market Research boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients' business needs.

This release was published on openPR.